20
Participants
Start Date
November 1, 2018
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
viral specific cytotoxic t-lymphocytes
CMV specific CTLs will be collected from HLA matched or mismatched donors and manufactured in a GMP facility and administered to patients with refractory CMV infection.
RECRUITING
New York Medical College, Valhalla
RECRUITING
Children's Hospital of Pennsylvania, Philadelphia
RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Nationwide Children's Hosptial, Columbus
RECRUITING
Indiana University, Indianapolis
RECRUITING
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee
RECRUITING
Washington University, St Louis
RECRUITING
Children's Hospital Los Angeles, Los Angeles
RECRUITING
University of California San Francisco, San Francisco
Lead Sponsor
Children's Hospital of Philadelphia
OTHER
Medical College of Wisconsin
OTHER
Nationwide Children's Hospital
OTHER
Johns Hopkins University
OTHER
University of California, San Francisco
OTHER
Washington University School of Medicine
OTHER
Indiana University
OTHER
Children's Hospital Los Angeles
OTHER
New York Medical College
OTHER